COVID-19 and diabetes: Analysis of the scientific production indexed in Scopus
- 10 March 2021
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (3), 765-770
- https://doi.org/10.1016/j.dsx.2021.03.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysisTravel Medicine and Infectious Disease, 2020
- Brazil burning! What is the potential impact of the Amazon wildfires on vector-borne and zoonotic emerging diseases? – A statement from an international experts meetingTravel Medicine and Infectious Disease, 2019
- Cuban Scientific Production on Diabetes, 2000-2017: Peer-reviewed Publications, Collaboration and Impact2019
- Constructing bibliometric networks: A comparison between full and fractional countingJournal of Informetrics, 2016
- The journal coverage of Web of Science and Scopus: a comparative analysisScientometrics, 2015
- The research guarantors of scientific papers and the output counting: a promising new approachScientometrics, 2013
- Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled AnalysisPLoS Medicine, 2011
- The R- and AR-indices: Complementing the h-indexChinese Science Bulletin, 2007
- An index to quantify an individual's scientific research outputProceedings of the National Academy of Sciences of the United States of America, 2005